Last 12 months
Inside the activity.
0 purchase rows · 34 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 18, 2024 Filed Jul 19, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-033595 · form4.xml · nonDerivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-033595 · form4.xml · derivative · entry 5 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,500 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $51.55 | $902,125.00 |
DisclosureSEC source: 0001140361-24-033595 · form4.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,937 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-033595 · form4.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 20:05 UTC |
Flynn Sean C.Chief Legal Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001140361-24-033484 · form4.xml · derivative · entry 3 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 15,000 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 20:05 UTC |
Flynn Sean C.Chief Legal Officer
|
SaleCommon Stock | 15,000 | $52.18 | $782,700.00 |
DisclosureSEC source: 0001140361-24-033484 · form4.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 707 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 20:05 UTC |
Flynn Sean C.Chief Legal Officer
|
Exercise / conversionCommon Stock | 15,000 | $16.25 | $243,750.00 |
DisclosureSEC source: 0001140361-24-033484 · form4.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 20:05 UTC |
Mara Joseph Anthony JrChief Financial Officer
|
SaleCommon Stock | 5,000 | $50.00 | $250,000.00 |
DisclosureSEC source: 0001140361-24-033292 · form4.xml · nonDerivative · entry 1 Mara Joseph Anthony Jr · CIK 0001841148 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,436 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:05 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
SaleCommon Stock | 545 | $45.00 | $24,525.00 |
DisclosureSEC source: 0001140361-24-032762 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,033 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2024 Filed Feb 13, 2025 21:05 UTC |
Halpin MichaelChief Operating Officer
|
GrantCommon Stock | 95 | $39.00 | $3,705.00 |
DisclosureSEC source: 0001140361-25-004301 · form5.xml · nonDerivative · entry 1 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,379 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 22:21 UTC |
Flynn Sean C.Chief Legal Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,474 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · derivative · entry 9 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 1,474 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 22:21 UTC |
Flynn Sean C.Chief Legal Officer
|
SaleCommon Stock | 1,474 | $45.84 | $67,568.16 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 6 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 487 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 22:21 UTC |
Flynn Sean C.Chief Legal Officer
|
Exercise / conversionCommon Stock | 1,474 | $16.25 | $23,952.50 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 5 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 21, 2024 Filed Jun 24, 2024 22:21 UTC |
Flynn Sean C.Chief Legal Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,772 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · derivative · entry 8 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,474 Underlying: Common Stock · 6,772 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| June 21, 2024 Filed Jun 24, 2024 22:21 UTC |
Flynn Sean C.Chief Legal Officer
|
SaleCommon Stock | 6,772 | $45.02 | $304,875.44 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 4 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 487 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 21, 2024 Filed Jun 24, 2024 22:21 UTC |
Flynn Sean C.Chief Legal Officer
|
Exercise / conversionCommon Stock | 6,772 | $16.25 | $110,045.00 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 3 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 22:21 UTC |
Flynn Sean C.Chief Legal Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,754 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · derivative · entry 7 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,246 Underlying: Common Stock · 6,754 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 22:21 UTC |
Flynn Sean C.Chief Legal Officer
|
SaleCommon Stock | 6,754 | $45.04 | $304,200.16 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 487 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 22:21 UTC |
Flynn Sean C.Chief Legal Officer
|
Exercise / conversionCommon Stock | 6,754 | $16.25 | $109,752.50 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-030179 · form4.xml · derivative · entry 6 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $43.10 | $754,250.00 |
DisclosureSEC source: 0001140361-24-030179 · form4.xml · nonDerivative · entry 4 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,752 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-030179 · form4.xml · nonDerivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-030179 · form4.xml · derivative · entry 5 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 192,500 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $44.12 | $772,100.00 |
DisclosureSEC source: 0001140361-24-030179 · form4.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,752 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-030179 · form4.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:05 UTC |
WRIGHT LISADirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 434 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-029005 · form4.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in equal annual installments over three years, beginning on June 1, 2021. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:05 UTC |
WRIGHT LISADirector
|
Exercise / conversionCommon Stock | 434 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-029005 · form4.xml · nonDerivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on June 1, 2021. Read SEC document |
| May 20, 2024 Filed May 21, 2024 20:07 UTC |
Hopper Jonathan MarkChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $10.95 | $0.00 |
DisclosureSEC source: 0001140361-24-027027 · form4.xml · derivative · entry 3 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,604 Underlying: Common Stock · 10,000 shares Expires 2028-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| May 20, 2024 Filed May 21, 2024 20:07 UTC |
Hopper Jonathan MarkChief Medical Officer
|
SaleCommon Stock | 10,000 | $49.99 | $499,900.00 |
DisclosureSEC source: 0001140361-24-027027 · form4.xml · nonDerivative · entry 2 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,116 F2 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 20, 2024 Filed May 21, 2024 20:07 UTC |
Hopper Jonathan MarkChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $10.95 | $109,500.00 |
DisclosureSEC source: 0001140361-24-027027 · form4.xml · nonDerivative · entry 1 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:05 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,132 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001140361-24-027025 · form4.xml · derivative · entry 4 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,132 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options, representing the right to purchase 40,330 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 7, 2018, which was one quarter after the date on which the option was granted. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:05 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,063 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001140361-24-027025 · form4.xml · derivative · entry 3 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,063 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on April 10, 2018, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:05 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionCommon Stock | 3,132 | $7.20 | $22,550.40 |
DisclosureSEC source: 0001140361-24-027025 · form4.xml · nonDerivative · entry 2 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:05 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionCommon Stock | 2,063 | $2.65 | $5,466.95 |
DisclosureSEC source: 0001140361-24-027025 · form4.xml · nonDerivative · entry 1 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-026682 · form4.xml · derivative · entry 6 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,000 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $47.85 | $837,375.00 |
DisclosureSEC source: 0001140361-24-026682 · form4.xml · nonDerivative · entry 4 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,752 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-026682 · form4.xml · nonDerivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-026682 · form4.xml · derivative · entry 5 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,500 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $49.67 | $869,225.00 |
DisclosureSEC source: 0001140361-24-026682 · form4.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,752 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-026682 · form4.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC |
WRIGHT LISADirector
|
GrantRestricted Stock Unit · Derivative | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-024335 · form4.xml · derivative · entry 4 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200 Underlying: Common Stock · 3,200 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC |
WRIGHT LISADirector
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $47.08 | $0.00 |
DisclosureSEC source: 0001140361-24-024335 · form4.xml · derivative · entry 3 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2034-05-01 F5 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC |
WRIGHT LISADirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-024335 · form4.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 3, 2024, or the date of the first Annual Meeting of Stockholders following May 3, 2023. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC |
WRIGHT LISADirector
|
Exercise / conversionCommon Stock | 3,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-024335 · form4.xml · nonDerivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on May 3, 2023. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC |
ZERBE ROBERT L MDDirector
|
GrantRestricted Stock Unit · Derivative | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-024334 · form4.xml · derivative · entry 4 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200 Underlying: Common Stock · 3,200 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC |
ZERBE ROBERT L MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $47.08 | $0.00 |
DisclosureSEC source: 0001140361-24-024334 · form4.xml · derivative · entry 3 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2034-05-01 F5 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-024334 · form4.xml · derivative · entry 2 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 3, 2024, or the date of the first Annual Meeting of Stockholders following May 3, 2023. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionCommon Stock | 3,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-024334 · form4.xml · nonDerivative · entry 1 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on May 3, 2023. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC |
Wotton Paul KDirector
|
GrantRestricted Stock Unit · Derivative | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-024333 · form4.xml · derivative · entry 4 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200 Underlying: Common Stock · 3,200 shares Expires not disclosed F2 · derivative.exercise_price: Upon the vesting of RSUs granted to the Reporting Person on May 3, 2023, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. F7 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC |
Wotton Paul KDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $47.08 | $0.00 |
DisclosureSEC source: 0001140361-24-024333 · form4.xml · derivative · entry 3 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2034-05-01 F6 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.